Modules for managing immune-related adverse events
There’s still limited knowledge on adverse events when treating patients with cancer immunotherapies. These adverse events may include the body’s own immune system attacking healthy tissues. We are actively working with leading centers in order to better understand and manage toxicities of Immune Checkpoint Inhibitor and CAR T Cell therapies.
Compliant with all cancer care pathways
- Systemic therapies
- Palliative care